Stanford University School of Medicine
Stanford, California, 94305, United States
NCT Number: NCT03118973
Randomized, prospective study evaluating efficacy and safety of Goff transpancreatic septotomy vs. double wire technique for achieving biliary access in patients who fail initial cannulation at ERCP.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Stanford, California, 94305, United States
Selective placement of a guidewire into the bile duct (biliary cannulation) during endoscopic retrograde cholangiopancreatography (ERCP) is necessary for performing therapeutic biliary procedures. The success rate for biliary cannulation by experienced endoscopists during ERCP is approximately 85% with standard cannulation techniques. Inadvertent placement of the guidewire into the pancreatic duct rather than the bile duct often occurs when attempting selective biliary cannulation in technically challenging cases. When this occurs repeatedly, other approaches may be used to facilitate selective biliary cannulation, but there are few prospective studies evaluating the efficacy and safety of these approaches. Here the investigators evaluate two approaches for technically challenging biliary cannulation: one involving maintenance of a wire in the pancreatic duct, followed by repeat attempt at biliary cannulation (double wire technique) and one involving a small incision in the septum adjacent to the pancreas followed by repeat attempt at biliary cannulation (transpancreatic septotomy). This study is a prospective randomized trial comparing the rate of cannulation success, procedure duration and complications following these two approaches.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Goff trans-pancreatic septotomy vs. Double wire technique for achieving biliary access when biliary cannulation is challenging.
Time frame: Day of procedure
Successful biliary cannulation
Time frame: 6 months
Rates of adverse events associated with the ERCP procedure following intervention to facilitate biliary cannulation.
Subhas Banerjee
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06960733
Bile Duct Stones, Biliary Obstruction
Leipzig, Saxony, Germany
View Trial DetailsNCT04857424
Biliary Obstruction
Rochester, Minnesota, United States
View Trial DetailsNCT07417020
Bile Duct Diseases, Bile Duct Disorder
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT04406961
Benign Biliary Strictures With Current or Prior Biliary Obstruction, Bile Duct Diseases
Odesa, Odesa Oblast, Ukraine
View Trial Details